NCT06572358View on ClinicalTrials.gov

A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects Having Symptoms of Gut Dysbiosis (Heart Burn, Bloating, Constipation and Gut Immunity).

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

February 7, 2025

Study Completion Date

February 7, 2025

Conditions
Gut Dysbiosis
Interventions
OTHER

MetProUltima

"Test product Name: MetProUltima Marketed By\

Trial Locations (1)

382481

NovoBliss Research Pvt.Ltd, Ahmedabad

Sponsors
All Listed Sponsors
collaborator

Meteoric Biopharmaceuticals Pvt. Ltd.

INDUSTRY

lead

NovoBliss Research Pvt Ltd

OTHER

NCT06572358 - A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects Having Symptoms of Gut Dysbiosis (Heart Burn, Bloating, Constipation and Gut Immunity). | Biotech Hunter | Biotech Hunter